M&A Deal Summary |
|
|---|---|
| Date | 2020-11-12 |
| Target | Two Labs |
| Sector | Life Science |
| Buyer(s) | Envision Pharma |
| Sellers(s) | Excellere Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Envision Pharma is a global technology and scientific communication company serving the pharmaceutical, biotechnology, and medical device companies. Envision has grown steadily under consistent leadership across its three core business areas that include scientific solutions – strategic publication planning and related data dissemination services, technology Solutions – design, development, implementation, and support of innovative and strategic management software for life sciences clients including publication planning and management (DatavisionTM), clearance approval (dvClear), and activity request management (Visiontracker) and professional consulting solutions policy, process, compliance and guideline consultancy to life-science companies. Envision Pharma was founded in 2001 and is based in Horsham, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 5 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 4 of 5 |
| State (Ohio) | 1 of 1 |
| Country (United States) | 2 of 3 |
| Year (2020) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-04-08 |
90TEN Group
London, United Kingdom 90TEN Group Ltd. is an independent healthcare communications consultancy that specialises in using proven behavioural change tools to maximise brand and health outcomes. The company delivers highly creative, award-winning global and international public relations, medical education and patient engagement programmes for pharmaceutical and healthcare clients. 90TEN Group was formed in 2001 and is based in London. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-22 |
doDOC
Boston, Massachusetts, United States doDOC is a Software as a Service (SaaS)-based platform that enables simultaneous collaboration in the review, editing, and authoring of documents among multiple users. Designed for the pharma and life sciences industries, it offers significant industry-specific advantages over general document authoring solutions in the market today. doDOC was founded in 2015 and is based in Boston, Massachusetts. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 2.3B USD |
| Size | Large |
| Type | Sector Agnostic |
Excellere Partners is a private equity firm focused on mid-market recapitalizations, management buyouts, and consolidation opportunities. Excellere looks to partner with management on transactions and targets opportunities in business services, education/training, healthcare, industrial services, and specialty foods. Excellere Partners was formed in 2006 and is based in Denver, Colorado.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 12 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 4 of 5 |
| State (Ohio) | 1 of 1 |
| Country (United States) | 9 of 12 |
| Year (2020) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-01 |
ADVENT
Milwaukee, Wisconsin, United States ADVENT is a provider of otolaryngology (“ENT”) services in Illinois and Wisconsin, seeking to improve patient outcomes by identifying, diagnosing, and treating the root causes of breathing and sleeping issues. ADVENT was founded in 2004 and is based in Milwaukee, Wisconsin. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-21 |
SCA Pharma
Little Rock, Arkansas, United States SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide. SCA Pharmaceuticals products and services have consistently proven to significantly increase efficiencies and reduce costs to these organizations. SCA Pharma was founded in 2010 and is based in Little Rock, Arkansas. |
Buy | - |
